house · trading 2012-04-24 → 2018-12-13
*Notional-weighted price return on disclosed buys from the last ~3 years, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2017-02-21 | STE | BUY | $1K–$15K | $69.81 | $217.05 2026-07-13 | +210.9% |
| 2017-02-21 | FANUY | BUY | $1K–$15K | $19.78 | $21.27 2026-07-13 | +7.5% |
| 2017-02-16 | ZTS | BUY | $1K–$15K | $52.78 | $75.39 2026-07-13 | +42.8% |
| 2017-02-16 | MFS | BUY | $1K–$15K | — | — | — |
| 2017-02-16 | CLOX | BUY | $1K–$15K | — | — | — |
| 2017-02-13 | IEX | BUY | $1K–$15K | $91.96 | $221.48 2026-07-13 | +140.8% |
| 2017-02-10 | XLRN | BUY | $1K–$15K | — | — | — |
| 2017-02-10 | WOOF | BUY | $1K–$15K | — | — | — |
| 2017-02-10 | WCN | BUY | $1K–$15K | $53.35 | $171.17 2026-07-13 | +220.8% |
| 2017-02-10 | GILD | BUY | $1K–$15K | $66.36 | $131.40 2026-07-13 | +98.0% |
| 2017-02-09 | MSFT | BUY | $1K–$15K | $64.06 | $390.99 2026-07-13 | +510.4% |
| 2017-02-09 | IPHI | BUY | $1K–$15K | — | — | — |
| 2017-02-09 | ABEV | BUY | $1K–$15K | $5.34 | $3.06 2026-07-13 | -42.7% |
| 2017-02-09 | AAPL | BUY | $1K–$15K | $33.10 | $317.31 2026-07-13 | +858.5% |
| 2017-02-08 | PM | BUY | $1K–$15K | $102.63 | $180.19 2026-07-13 | +75.6% |
| 2017-02-08 | INTU | BUY | $1K–$15K | $116.55 | $289.76 2026-07-13 | +148.6% |
| 2017-02-08 | FTV | BUY | $1K–$15K | $35.43 | $62.31 2026-07-13 | +75.9% |
| 2017-02-08 | FMC | BUY | $1K–$15K | $49.64 | $10.91 2026-07-13 | -78.0% |
| 2017-02-08 | DBSDY | BUY | $1K–$15K | $48.49 | $218.67 2026-07-13 | +350.9% |
| 2017-02-08 | CVS | BUY | $1K–$15K | $77.03 | $105.90 2026-07-13 | +37.5% |
| 2017-02-08 | BMY | BUY | $1K–$15K | $52.00 | $59.34 2026-07-13 | +14.1% |
| 2017-02-08 | BIVV | BUY | $1K–$15K | $42.96 | $104.98 2018-03-08 | +144.4% |
| 2017-02-08 | BIO.B | BUY | $1K–$15K | $187.42 | $309.37 2026-07-13 | +65.1% |
| 2017-02-08 | BAC | BUY | $1K–$15K | $22.67 | $59.50 2026-07-13 | +162.5% |
| 2017-02-07 | STO | BUY | $1K–$15K | — | — | — |
| 2017-02-07 | ELU | BUY | $1K–$15K | $22.92 | $25.08 2020-12-18 | +9.4% |
| 2017-02-07 | CRZO | BUY | $1K–$15K | — | — | — |
| 2017-02-03 | IEX | BUY | $1K–$15K | $91.03 | $221.48 2026-07-13 | +143.3% |
| 2017-02-03 | CVS | BUY | $1K–$15K | $75.46 | $105.90 2026-07-13 | +40.3% |
| 2017-02-02 | WPYG | BUY | $1K–$15K | — | — | — |
| 2017-02-02 | TELNF | BUY | $1K–$15K | — | — | — |
| 2017-02-02 | SHKG | BUY | $1K–$15K | — | — | — |
| 2017-02-02 | ALOY | BUY | $1K–$15K | $42.00 | $11.07 2026-07-13 | -73.6% |
| 2017-01-30 | VWR | BUY | $1K–$15K | — | — | — |
| 2017-01-30 | TYPE | BUY | $1K–$15K | — | — | — |
| 2017-01-30 | THRM | BUY | $1K–$15K | $34.65 | $36.12 2026-07-13 | +4.2% |
| 2017-01-30 | STE | BUY | $1K–$15K | $70.03 | $217.05 2026-07-13 | +209.9% |
| 2017-01-30 | QLYS | BUY | $1K–$15K | $36.40 | $151.54 2026-07-13 | +316.3% |
| 2017-01-30 | PRLB | BUY | $1K–$15K | $52.00 | $74.72 2026-07-13 | +43.7% |
| 2017-01-30 | MD | BUY | $1K–$15K | $67.94 | $26.14 2026-07-13 | -61.5% |
| 2017-01-30 | HELE | BUY | $1K–$15K | $92.35 | $27.74 2026-07-13 | -70.0% |
| 2017-01-30 | GWA | BUY | $1K–$15K | $0.14 | $0.14 2016-09-28 | 0.0% |
| 2017-01-30 | GPOR | BUY | $1K–$15K | — | — | — |
| 2017-01-27 | STLD | BUY | $1K–$15K | $36.23 | $234.14 2026-07-13 | +546.3% |
| 2017-01-27 | PNRA | BUY | $1K–$15K | — | — | — |
| 2017-01-27 | IMAX | BUY | $1K–$15K | $33.05 | $38.35 2026-07-13 | +16.0% |
| 2017-01-27 | ELF | BUY | $1K–$15K | $25.29 | $75.10 2026-07-13 | +197.0% |
| 2017-01-27 | DBSDY | BUY | $1K–$15K | $49.04 | $218.67 2026-07-13 | +345.9% |
| 2017-01-26 | PNC | BUY | $1K–$15K | $121.63 | $252.85 2026-07-13 | +107.9% |
| 2017-01-26 | PFE | BUY | $1K–$15K | $29.68 | $24.48 2026-07-13 | -17.5% |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Josh Gottheimer | 125 · AMAT, COST, CVX, DLTR, FCX, GD |
| SUSAN M COLLINS | 106 · APC, BAC, BMY, C, CVX, ESRX |
| Thomas H Tuberville | 102 · AMAT, BMY, CSX, CVX, FCX, GD |
| Sheldon Whitehouse | 97 · BAC, BMY, COST, C, CSX, ESRX |
| Lois Frankel | 96 · AMAT, APC, C, ESRX, GD, JPM |
| Gilbert Cisneros | 92 · AMAT, BMY, COST, JPM, MU, PFE |
| Rohit Khanna | 92 · AMAT, BAC, C, JPM, MET, MS |
| K. Michael Conaway | 85 · BAC, BMY, COST, CVX, DLTR, ESRX |
| Thomas R Tillis | 83 · BECN, CRZO, CTCT, MDCA, PBH, TUMI |
| Shelley M Capito | 81 · BMY, COST, C, CSX, CVX, GD |
| Alan S. Lowenthal | 80 · BAC, BMY, COST, C, ESRX, GD |
| John A. Yarmuth | 80 · BAC, BMY, COST, C, CSX, CVX |